Arno Therapeutics, Inc.
ARNI · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,508 | $7,771 | -$39,657 | -$14,388 |
| Dep. & Amort. | $8 | $13 | $13 | $14 |
| Deferred Tax | $2 | $0 | $0 | -$2,807 |
| Stock-Based Comp. | $3,473 | $4,524 | $1,457 | $723 |
| Change in WC | -$20 | -$1,919 | $786 | $777 |
| Other Non-Cash | -$1,921 | -$29,193 | $23,158 | $6,261 |
| Operating Cash Flow | -$9,966 | -$18,805 | -$14,243 | -$9,420 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$20 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | $0 | -$20 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,097 | -$0 | $0 | $14,857 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$13 | $0 | $10,648 | -$1,172 |
| Financing Cash Flow | $2,084 | -$0 | $30,073 | $13,685 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,881 | -$18,826 | $15,831 | $4,265 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,948 | $26,774 | $10,943 | $6,678 |
| End Cash | $67 | $7,948 | $26,774 | $10,943 |
| Free Cash Flow | -$9,966 | -$18,826 | -$14,243 | -$9,420 |